Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP512296.RA3EP7Qm7oDRw5g0XTOr2FWNWUQ9oKswKa5Mwp8CFv7mA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP512296.RA3EP7Qm7oDRw5g0XTOr2FWNWUQ9oKswKa5Mwp8CFv7mA130_assertion type Assertion NP512296.RA3EP7Qm7oDRw5g0XTOr2FWNWUQ9oKswKa5Mwp8CFv7mA130_head.
- NP512296.RA3EP7Qm7oDRw5g0XTOr2FWNWUQ9oKswKa5Mwp8CFv7mA130_assertion wasGeneratedBy ECO_0000203 NP512296.RA3EP7Qm7oDRw5g0XTOr2FWNWUQ9oKswKa5Mwp8CFv7mA130_provenance.
- NP512296.RA3EP7Qm7oDRw5g0XTOr2FWNWUQ9oKswKa5Mwp8CFv7mA130_assertion wasDerivedFrom befree-20140225 NP512296.RA3EP7Qm7oDRw5g0XTOr2FWNWUQ9oKswKa5Mwp8CFv7mA130_provenance.
- NP512296.RA3EP7Qm7oDRw5g0XTOr2FWNWUQ9oKswKa5Mwp8CFv7mA130_assertion SIO_000772 21471514 NP512296.RA3EP7Qm7oDRw5g0XTOr2FWNWUQ9oKswKa5Mwp8CFv7mA130_provenance.
- NP512296.RA3EP7Qm7oDRw5g0XTOr2FWNWUQ9oKswKa5Mwp8CFv7mA130_assertion evidence source_evidence_literature NP512296.RA3EP7Qm7oDRw5g0XTOr2FWNWUQ9oKswKa5Mwp8CFv7mA130_provenance.
- NP512296.RA3EP7Qm7oDRw5g0XTOr2FWNWUQ9oKswKa5Mwp8CFv7mA130_assertion description "[Interestingly, reducing ChREBP(OG) levels via OGA overexpression decreased lipogenic protein content (ACC, FAS), prevented hepatic steatosis, and improved the lipidic profile of OGA-treated db/db mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP512296.RA3EP7Qm7oDRw5g0XTOr2FWNWUQ9oKswKa5Mwp8CFv7mA130_provenance.